Abstract:OBJECTIVE To evaluate the effect of intravenous immunoglobulin (IVIG) and vitamin C on the progression of experimental autoimmune myocarditis(EAM). METHODS Fifty-two Balb/c mice were randomized into six groups: The blank group received no treatment, the remaining 5 groups were immunized with 100mug emulsified porcine myosin at d 1 and d 7. Different agents were injected from d 1, SVitC group:150 mg/kg*d(-1)vitamin C; LVitC group: 300 mg/kg*d(-1)vitamin C; IVIG group: 1 g/kg*d(-1)IVIG; IVIG+VitC group: 1 g/kg*d(-1)IVIG and 150 mg/kg*d(-1)vitamin C; The control group same volume of normal saline. All mice were sacrificed at d 21, and serum TNF-alpha levels were detected with enzyme linked immunosorbent assay (ELISA). The ratio of heart to body weight(C/W), spleen to body weight(S/W) and kidney to body weigh(R/W) were calculated. The spleens and heart were examined pathologically and/or immunohistochemically. RESULT Compared with those of control group, inflammatory cells infiltration in the myocardium and calcification in the pericardiume in SVitC and LVitC groups were extenuated. There were inflammatory cells infiltrating in the myocardium sparely and no calcification in the pericardium in IVIG and IVIG+VitC groups. The size of spleens enlarged especially in IVIG and IVIG+VitC groups. White and red pulps of spleens were hyperplastic microscopically. The C/W of treatment groups decreased significantly compared with that of control group. The S/W of therapy groups and control group was significantly higher than that of blank group; and the S/W of IVIG and IVIG + VitC groups was significantly higher than that of SVitC and LVitC groups. The R/W in each groups had no significant difference. The TNF-alpha level in SVitC and LVitC groups was a little lower than that in control group; TNF-alpha level in IVIG and IVIG+VitC groups was significantly lower than that of control group. Wide fluorescence stripe was found along extracellular matrix surrounding the damaged cardiomyocytes of control group. Both density and intensity of fluorescence in SVitC and LVitC groups were lower than those of control group. There were much wider fluorescence stripe and strengthened intensity in IVIG and IVIG + VitC groups. The myofilaments were in wild disorder and sarcomere had severe breakage in control group. Moreover, chondriosome hypertrophy and vacuolar degeneration were found. The damage lessened in SVitC and LVitC groups. Both myofilaments and sarcomeres in IVIG and IVIG + VitC groups were almost normal, and the chondriosome was normal. CONCLUSION IVIG and vitamin C have some protective and therapeutic effect on the progression of EAM by decreasing pathological damage of myocardium and depressing TNF-alpha production, and IVIG combined with vitamin C is more effective.

Cardioprotective Effects of Carvedilol on Acute Autoimmune Myocarditis

Cardioprotective Effects of Carvedilol on Acute Autoimmune Myocarditis: Anti-Inflammatory Effects Associated with Antioxidant Property

Carvedilol Ameliorates Autoimmune Myocarditis by Its Antioxidant Property

Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.

[Effect of Intravenous Immunoglobulin and Vitamin C on Progression of Experimental Autoimmune Myocarditis in Mice].

Changes of Calcium Handling Protein after Acute Myocardial Infarction in Rats and Effect of Carvedilol

Effect of Β-Blockers on Cardiac Function and Calcium Handling Protein in Postinfarction Heart Failure Rats

Protective Effects of Carvedilol on Rats Cardiomyocytes Exposed to Adriamycin

Effects of Carvedilol on Cardiac Cytokines Expression and Remodeling in Rat with Acute Myocardial Infarction

Carvedilol Protects Early Diabetic Rat Hearts through Reducing Oxidative Stress.

Carvedilol Ameliorates Sympathetic Nerve Sprouting and Electrical Remodeling after Myocardial Infarction in Rats

Protective effects of S-carvedilol on doxorubicin-induced damages to human umbilical vein endothelial cells and rats.

Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor

[Effects of Carvedilol and Metoprolol on Cardiac Fibrosis in Rats with Experimental Myocardial Infarction].

Protective Effects of Carvedilol against the Adriamycin-induced Cardiotoxicity

Effect of Carvedilol on Myocardial Extracellular Matrix Remodeling in Rats after Acute Myocardial Infarction

Beneficial Effects of Olmesartan, a Novel Angiotensin II Receptor Type 1 Antagonist, Upon Acute Autoimmune Myocarditis.

Cardioprotective effect of carvedilol: inhibition of apoptosis in H9c2 cardiomyocytes via the TLR4/NF-κB pathway following ischemia/reperfusion injury

Comparison Of Low And High Doses Of Carvedilol On Restoration Of Cardiac Function And Calcium-Handling Proteins In Rat Failing Heart

The Protective Effects of Carvedilol on the Adriamycin-induced Cardiotoxicity

Carvedilol improved diabetic rat cardiac function depending on antioxidant ability.